BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11144309)

  • 1. Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit.
    Ohler KH; Menke JA; Fuller L
    Am J Perinatol; 2000; 17(6):285-90. PubMed ID: 11144309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gentamicin and tobramycin in neonates: comparison of a new extended dosing interval regimen with a traditional multiple daily dosing regimen.
    Avent ML; Kinney JS; Istre GR; Whitfield JM
    Am J Perinatol; 2002 Nov; 19(8):413-20. PubMed ID: 12541213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of extended-interval gentamicin dosing for neonatal patients in developing countries.
    Darmstadt GL; Hossain MM; Jana AK; Saha SK; Choi Y; Sridhar S; Thomas N; Miller-Bell M; Edwards D; Aranda J; Willis J; Coffey P
    Pediatr Infect Dis J; 2007 Jun; 26(6):501-7. PubMed ID: 17529867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels.
    Hansen A; Forbes P; Arnold A; O'Rourke E
    J Perinatol; 2003 Dec; 23(8):635-9. PubMed ID: 14647159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
    Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
    Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once daily dose gentamicin in neonates - is our dosing correct?
    Serane TV; Zengeya S; Penford G; Cooke J; Khanna G; McGregor-Colman E
    Acta Paediatr; 2009 Jul; 98(7):1100-5. PubMed ID: 19397541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic variability of extended interval tobramycin in burn patients.
    Bracco D; Landry C; Dubois MJ; Eggimann P
    Burns; 2008 Sep; 34(6):791-6. PubMed ID: 18395988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
    Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside pharmacokinetic parameters in neurocritical care patients undergoing induced hypothermia.
    Mercer JM; Neyens RR
    Pharmacotherapy; 2010 Jul; 30(7):654-60. PubMed ID: 20575630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a dosage individualization table for extended-interval gentamicin in neonates.
    Dersch-Mills D; Akierman A; Alshaikh B; Yusuf K
    Ann Pharmacother; 2012; 46(7-8):935-42. PubMed ID: 22739714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life.
    Cooper AC; Commers AR; Finkelstein M; Lipnik PG; Tollefson LM; Wilcox RA; Hoff DS
    Pharmacotherapy; 2011 Jul; 31(7):649-57. PubMed ID: 21923451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
    Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
    Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended interval dosing of gentamicin in preterm infants.
    Mercado MC; Brodsky NL; McGuire MK; Hurt H
    Am J Perinatol; 2004 Feb; 21(2):73-7. PubMed ID: 15017470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of once-daily versus twice-daily gentamicin dosing regimens in infants > or = 2500 g.
    Agarwal G; Rastogi A; Pyati S; Wilks A; Pildes RS
    J Perinatol; 2002 Jun; 22(4):268-74. PubMed ID: 12032787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.